Solventum, formerly 3M’s healthcare business, will spend $209 million on a new headquarters in Minnesota, state economic development officials announced today. The Minnesota Department of Employment and Economic Development said the state will provide nearly $13 million in business development funding to support the project, which will retain an estimated 2,000 jobs in the North […]
Minnesota
7 startups grabbing the medtech spotlight in Minnesota
Minnesota has long been one of the nation’s top three medtech hubs and a good place for startups to get their footing. For 17 years, the MN Cup contest has offered cash prizes and the opportunity for medtech (and other) startups to tap into expert help to accelerate their businesses. MN Cup is a community-led, public-private partnership that […]
Boston Scientific to expand its Maple Grove, Minn. campus
Boston Scientific (NYSE:BSX) is planning a fourth building at its Maple, Grove, Minn. campus to support expanded nitinol stent manufacturing. The Maple Grove Planning Commission is scheduled to review project plans tonight for the roughly 76,000 ft2 building. “Subject to city approval, we hope to begin construction on a new building on our Maple Grove […]
The top 10 medical device states: Everything you need to know
California, Minnesota and Massachusetts dominate the U.S. medical device industry. But many other states also play a significant role in medtech. From industry employment to venture capital investment to number of major headquarters, read on and discover how the medical device industry’s top states compare. Next>> This story originally ran Feb. 6, 2019. Updated Feb. […]
2 Minnesota medical device industry suppliers are expanding
Two Minnesota-based medical device industry suppliers – Windings and New Plastics Plus – are expanding and adding jobs, the state’s Department of Employment and Economic Development recently announced. Get the full story on our sister site Medical Design & Outsourcing.
3 ways HHS can help medtech innovators
The U.S. Department of Health and Human Services (HHS) is doing everything from sharing more data to cultivating entrepreneurial talent and engaging in partnerships in order to support medical device innovators, the department’s CTO Ed Simcox told than 100 industry insiders in the Twin Cities today. A major goal at HHS is to build an innovation-focused […]
More information out about One Discovery Square near Mayo Clinic
A new website is providing more details — including a new anchor tenant —for One Discovery Square, the roughly 90,000-square-foot biotech research, collaboration and innovation space under construction near Mayo Clinic in Rochester, Minn. Slated to open in April 2019, the four-story building is meant to be the first step in the creation of an innovation […]
Minnesota 2.0: Can this major U.S. medical device cluster become a healthcare innovation hub?
Minnesota has the institutions and the talent to transform healthcare in the U.S. The question is whether the money will follow. RxFunction makes wearable devices called “Walkasins” that help people with chronic health conditions prevent falls that can lead to serious injury. It took eight painstaking years, though, before the Eden Prairie, Minn.-based startup secured […]
Minnesota sees major medical device plant expansions
Medical device manufacturers are spending tens of millions of dollars on Minnesota plant expansions, but another heartening sign that the major device hub around the Minneapolis-St. Paul remains robust. LISI Medical Remmele—a maker of minimally invasive surgical devices, spinal implants, and drug infusion, urologic and vascular components—plans to nearly double the size of its Big Lake, […]
Medtech investment in Minnesota falls back to earth
After an off-the-charts year in investment for 2014, the Minnesota bioscience industry has seen a more typical 1st quarter, according to a report from medtech lobby LifeScience Alley.
Medtech investment hits 6-year high in Minnesota
Investment in Minnesota’s thriving medtech scene hit a 6-year high in 2014 and the state saw a significant jump in pharma/biotech investments, according to LifeScience Alley’s annual report.
